Synergistic combinations of macrolide T-cell modulator or inmunosuppressant and a retinoid

Details for Australian Patent Application No. 2004226819 (hide)

Owner Novartis AG

Inventors Grassberger, Maximilian; Mayer, Friedrich Karl; Paul, Carle; Hirsch, Stefan; Meingassner, Josef Gottfried; Sekkat, Nabila; Stutz, Anton

Agent Davies Collison Cave

Pub. Number AU-B-2004226819

PCT Pub. Number WO2004/087118

Priority 0307864.9 04.04.03 GB

Filing date 2 April 2004

Wipo publication date 14 October 2004

Acceptance publication date 28 February 2008

International Classifications

A61K 31/05 (2006.01)

A61K 31/07 (2006.01)

A61K 31/436 (2006.01)

A61P 17/00 (2006.01) Drugs for dermatological disorders

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/087118 Priority application(s): WO2004/087118

28 February 2008 Application Accepted

  Published as AU-B-2004226819

26 June 2008 Standard Patent Sealed

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226820-Combination of a macrolide T-cell immunomodulator and a calciferol for the treatment of skin diseases or of inflammatory bowel disease

2004226818-Compositions comprising macrolide Tcell immunomodulators or immunosuppressants in combination with antibacterials